Zantac / Ranitidine (NDMA Cancer) Attorney in San Jose, California

Zantac Litigation in San Jose / Silicon Valley

San Jose and Santa Clara County offer California state court filing under the favorable Frye/Kelly expert admissibility standard. California courts have denied multiple defense Daubert-equivalent motions in Zantac cases, allowing causation experts to proceed to trial. The Bay Area's high prescription drug utilization rates and tech-industry employees with comprehensive insurance coverage create strong documentation trails for ranitidine use. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Documentation for San Jose Zantac Claimants

San Jose-area Zantac claimants should gather pharmacy records from Walgreens, CVS, Safeway, and employee benefits pharmacy programs. Stanford Cancer Center South Bay and El Camino Health records document cancer diagnosis and treatment. California's 2-year SOL with the discovery rule — applied from the date the Zantac-NDMA-cancer connection was discoverable — governs filing windows.